Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials have?
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials has 85 citations in the OpenAlex counts ScholarIQ stores.
When was Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials published?
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials has 2022 year in the ScholarIQ index.
What is the open-access status of Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials?
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials has gold oa status in the ScholarIQ index.
What is the DOI of Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials?
The DOI for Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials is on the source record.
What is the PMID of Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials?
The PMID for Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials is on the source record.
What is the OpenAlex record for Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials?
The OpenAlex for Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials is on the source record.